Table 3.
Baseline characteristics and clinical data of non‐COVID and COVID‐19 patients
| Variables | Total (n = 75) | Non‐COVID (n = 50) | COVID‐19 (n = 25) | P valve |
|---|---|---|---|---|
| Sex | ||||
| Male | 50 (66.7) | 32 (64) | 18 (72) | .488 |
| Female | 25 (33.3) | 18 (36) | 7 (28) | |
| Age, y | 60.35 ± 11.23 | 61.86 ± 8.45 | 507.33 ± 15.13 | .174 |
| DM | 52 (42.7) | 52 (44) | 10 (40) | .741 |
| HTN | 42 (56) | 28 (56) | 14 (56) | 1.000 |
| Smoking | 13 (17.3) | 8 (16) | 5 (20) | .750 |
| Types of operation | ||||
| CABG | 52 (69.3) | 37 (74%) | 15 (60%) | .467 |
| VALVE | 9 (12) | 5 (10%) | 4 (16%) | |
| CABG + VALVE | 5 (6.7) | 2 (4%) | 3 (12%) | |
| Others | 9 (12) | 6 (12) | 3 (12) | |
| History of respiratory disease | 6 (8.1) | 2 (4.1) | 4 (16) | .171 |
| Number of grafts | 22.93 ± 99 (n = 58) | 3.28 ± 0.93 (n = 40) | 2.17 ± 0.62 (n = 18) | <.001 |
| Off‐pump/on‐pump | ||||
| Off‐pump | 11 (14.7) | 7 (14) | 4 (16) | .999 |
| On‐pump | 64 (85.3) | 413 (86) | 21 (84) | |
| CPB time, min | 97.17 ± 53.77 (n = 63) | 95.98 ± 49.64 (n = 43) | 99.75 ± 63.6 (n = 20) | .798 |
| LVEF, % | 44.73 ± 8.96 | 45.30 ± 9.23 | 43.60 ± 8.31 | .192 |
| ICU LOS, d | 2 (99‐303) | 1.88 (0.92‐3.04) | 3 (2‐4) | .002 |
| Intubation time, h | 14 (10‐18) | 14 (10‐18) | 13 (9.5‐18) | .723 |
| Readmission to ICU | 4 (5.3) | 0 | 4 (16) | |
| Hb, mg/dL | 12.69 ± 2.25 | 13.88 ± 1.55 | 10.32 ± 1.39 | <.001 |
| Reoperation | 4 (5.3) | 1 (2) | 3 (12) | .105 |
| Mortality | 5 (6.7) | 1 (2) | 4 (16) | .040 |
Note: Data are presented as mean ± SD or median (interquartile range) or n (%).
Abbreviations: CABG, coronary artery bypass graft; CPB, cardiopulmonary bypass; CABG, coronary artery bypass graft; DM, diabetes mellitus; HTN, hypertension; ICU, intensive care unit; LVEF, left ventricular ejection fraction.